CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2025	Jun. 30, 2024
Cash flows from operating activities:
Net income (loss)	$ 27,225	$ (29,802)
Adjustments to reconcile net (loss) income to net cash used in operating activities:
Accretion of discount on investments	(1,034)	(936)
Non cash lease expense	905	746
Change in fair value of 2023 common warrants	(63,176)	(16,106)
Depreciation expense	453	538
Stock-based compensation including ESPP	2,119	4,704
Changes in operating assets and liabilities:
Other assets	190	342
Accounts payable	1,328	4,302
Accrued liabilities	(3,352)	(4,778)
Operating lease liabilities	(1,499)	(1,267)
Deferred revenue	428	18
Net cash and cash equivalents used in operating activities	(36,413)	(42,239)
Activities in available-for-sale investments:
Maturities of short-term investments	20,000	40,000
Purchase of short-term investments	(103,336)	(88,573)
Purchases of property and equipment	(152)	(76)
Net cash and cash equivalents used in investing activities	(83,488)	(48,649)
Cash flows from financing activities:
Proceeds from issuance of common stock, common warrants and pre-funded warrants in connection with PIPE Offering, net of costs	101,386
Payments on finance lease	(1)	(35)
Proceeds from the ESPP purchase	180	297
Net cash and cash equivalents provided by financing activities	101,565	262
Net decrease in cash, cash equivalents, and restricted cash	(18,336)	(90,626)
Cash, cash equivalents, and restricted cash, beginning of period	37,107	135,774
Cash, cash equivalents, and restricted cash, end of period	18,771	45,148
Supplemental disclosures of noncash financing and investing activities:
PIPE issuance costs unpaid at period end	$ (41)	$ 0